Fisher & Paykel Healthcare's stock soared 6.19% during intraday trading on Monday, reflecting strong investor sentiment.
The surge follows the company's announcement that it now expects operating revenue to be approximately NZ$2.30 billion and net profit after tax to be in the range of NZ$450 million to NZ$470 million for the fiscal year ending March 31. This upgraded guidance has boosted confidence in the company's financial performance.
Health technology stocks broadly gained on the exchange, with Fisher & Paykel Healthcare leading the sector's advance.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.